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Abstract A 5.1 kb cDNA encoding an inward rectifier K+ 
channel (BIK) was isolated from a bovine aortic endothelial cell 
library. The cDNA codes for a 427-amino-acid protein with two 
putative transmembrane regions. Sequence analysis reveals that 
BIK is a member of the Kir2.1 family of inward rectifier K+ 
channels. Expression in Xenopus oocytes showed that BIK is a 
K+-specific strong inward rectifier channel that is sensitive to 
extracellular Ba2+, Cs+, and a variety of anti-arrhythmic agents. 
Northern analysis revealed that endothelial cells express a 5.5 kb 
BIK mRNA that is sensitive to shear stress. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The endothelial lining of blood vessels is exposed to a wide 
range of hemodynamic shear-stress environments [1,2]. Arte-
rial endothelial cells sense mechanical shear stress and trans-
duce it into a variety of biophysical, biochemical, and gene 
regulatory responses [3-6]. The initial mechanotransduction 
mechanism(s) has not been identified, however. A logical 
starting point to look for the primary mechanotransduction 
mechanism is with the fastest responses. One of the most 
rapid responses of endothelial cells to shear stress is the open-
ing of an inwardly rectifying K+ channel with simultaneous 
hyperpolarization of the endothelial cell membrane [7,8]. A 
previous study using potential sensitive dyes demonstrated a 
flow-induced hyperpolarization of endothelial cells [9]. Fur-
thermore, studies of unidirectional Rb + efflux by Alevriadou 
et al. [10] confirm shear stress-dependent membrane perme-
ability to K+. 
A variety of ionic conductances are observed in electrophys-
iological studies of arterial endothelial cells [11,12]. The ma-
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jor voltage-gated current observed in endothelial cells (/κι) is 
K+ specific [8,11,13-16]. 7χι has the properties of a K+ in-
ward rectifier: it is blocked by both extracellular Ba2+ and 
Cs+ ; it is strongly inwardly rectifying with a reversal potential 
near the potassium equilibrium potential; and its amplitude is 
a function of extracellular potassium concentration [11,12,17]. 
Depolarization of endothelial cells relative to the membrane 
potential (Km) elicits small outward currents, while hyperpo-
larizing voltage steps give rise to large inward currents 
[11,12,18]. The assumed role of the endothelial K+ inward 
rectifier is to set the endothelial cell Vm [15,18,19]. In bovine 
aortic endothelial cells (BAEC) the Vm is reported to be ap-
proximately —64 mV, which is near the —70 mV physiological 
potassium equilibrium potential [20,21]. This indicates that, in 
BAECs, Vm is primarily determined by K
+ . The addition of 
Ba2+ and Cs+ at inhibitory concentrations for inward recti-
fiers (100 μΜ and 2 mM, respectively) causes depolarization 
of BAECs [8,20]. Thus changes in the inwardly rectifying cur-
rent can modify the Vm of endothelial cells. This change in Vm 
modulates the electrochemical gradient for Ca2+, which deter-
mines the magnitude of Ca+2 influx from the extracellular 
space [22,23]. Intracellular Ca2+ is an important endothelial 
signaling molecule that mediates a wide variety of intracellular 
events [24]. 
In this paper we report the cDNA cloning and functional 
expression of a bovine aortic endothelial cell K+ inward rec-
tifier channel, BIK. The primary structure and electrophysio-
logical properties of BIK are presented. Inhibition of the BIK 
current by a variety of cations and pharmacological agents is 
examined. Finally, we demonstrate that the expression BAEC 
BIK mRNA significantly decreases in response to fluid flow. 
Preliminary results of this study were presented in abstract 
format [25]. 
2. Materials and methods 
2.1. Endothelial cell isolation and growth 
Clonal endothelial cells were mechanically isolated and cultured [26] 
using a modification of the techniques described by Gajdusek [27]. 
The identity of the cell lines was verified by morphology, diacetylated 
LDL uptake [28] and immunofluorescent labeling of factor VIII ex-
pression [29]. All cells were used before the 15th passage. A parallel 
plate flow chamber [26] was used to subject the endothelial cells to a 
well-defined laminar shear stress of 30 dyn/cm2 for 24 h. 
2.2. cDNA cloning and sequencing 
Polymerase chain reaction (PCR) was used to obtain a DNA probe 
for hybrid screening of a bovine aortic cDNA library. Two degenerate 
primers were synthesized according to the amino acid sequences con-
served between the mouse Kir2.1 [30] and the rat Kir2.2 [31]. The 
sequences of the sense and antisense oligonucleotide primers were 
5'-ATYGTNGGNTGYATHATHGA-3' and 5'-YTCRTTYTCRTA-
RCARAANSYRTTNGC-3', respectively, corresponding to amino 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00514-0 
278 S.E. Forsyth et al.lFEBS Letters 409 (1997) 277-282 
acid residues 166-171 and 371-379 of the mouse Kir2.1 [30], The 
cDNA was synthesized using M-MLV reverse transcriptase (Gibco), 
random hexamers (Gibco), and BAEC total RNA. PCR was carried 
out by Taq DNA polymerase (Promega) with 100 ng of cDNA and 
2 mM Mg2+ for 35 cycles under the following conditions: 95°C, 
1 min; 50°C, 1.5 min; 72°C, 2 min. The amplified product was sub-
cloned into the PCR II vector (Invitrogen) and sequenced using an 
Applied Biosystems 373A DNA Sequencer with DyeDeoxy termina-
tors (ABI). Sequence analysis of the 640 bp fragment (PCGene soft-
ware package) revealed that it was 88% homologous to the corre-
sponding region of the mouse Kir2.1 [30], This 640 bp fragment 
(BalO) was used to screen a bovine aortic endothelial cell cDNA 
library constructed in the phage λΖΑΡΙΙ (Stratagene). Screening was 
done on 1.5 XlO6 plaque forming units using the ECL direct nucleic 
acid labeling and detection system (Amersham) according to the man-
ufacturer's protocols. In vivo excision and rescue of pBluescript 
SK(—) from the positive λΖΑΡΙΙ clones were performed according 
to the manufacturer's instructions. We selected one clone with a 
5.0 kb insert for further characterization. Both strands of the clone 
were sequenced as described above. 
2.3. Northern blot analysis 
Total RNA was isolated from clonal bovine aortic endothelial cells 
using the acid guanidinium/phenol method [32]. RNA (10 μg) was 
electrophoresed on a 1% agarose gel containing formaldehyde and 
transferred by pressure blotting using the PosiBlot Pressure Blotter 
(Stratagene) onto a BrightStar Plus positively charged nylon mem-
brane (Ambion). BrightStar BIOTINscript (Ambion) was used to 
make biotin labeled RNA probes for hybridization. The BalO clone 
and the mouse GAPDH Control Vector (Ambion) were used as tem-
plates for probe synthesis. The filter was first hybridized with the BalO 
probe for 16 h at 65°C and washed at 65°C according to the manu-
facturer's protocols from NorthernMax (Ambion). Detection of the 
biotinylated RNA probe was done using BrightStar BioDetect (Am-
bion). Autoradiography was performed on Kodak Biomax MR film 
for 5 min at room temperature. Rehybridizations were done subse-
quently with the GAPDH probe following the protocol described 
above. The films with the GAPDH signal were exposed for 1 min. 
The intensity of each hybridization band was determined by optical 
densitometry (Personal Densitometer SI and ImageQuant, Molecular 
Dynamics). 
2.4. Functional expression of BIK 
The pBluescript SK(—) plasmid containing the BIK clone was lin-
earized with EcoKV and capped run-off cRNA was synthesized in 
vitro with T3 RNA polymerase. The transcribed RNA was injected 
into defolliculated Xenopus oocytes (27 ng RNA/oocyte) [33] followed 
by incubation for 48 h. Channel expression was measured by two 
microelectrode voltage clamping with a cutoff frequency of 2 kHz 
(8-pole Bessel filter). Electrodes (1-3 ΜΩ) filled with 3 M KC1 were 
used. The pClamp software was used for data acquisition and analy-
sis. Bath solution (ND96) contained 96 mM NaCl, 2 mM KC1, 1 mM 
MgCl2, 1.8 mM CaCl2, 0.3 mM niflumic acid and 5 mM HEPES (pH 
7.5). Solutions with various concentrations of K+ were made by sub-
stituting equimolar concentrations of K+ for Na+ in ND96. 
2.5. Pharmacological agents 
Quinidine [34], disopyramide [35] and niflumic acid were purchased 
from Sigma. Sotalol [36] and compound II [37] were purchased from 
Tocris Cookson. 
3. Results 
3.1. Primary structure of BIK 
Fifteen positive cDNA clones were isolated from a bovine 
aortic endothelial cell cDNA library. The nucleotide sequence 
of the largest clone (BIK) contains one long open reading 
frame encoding a protein of 427-amino-acid residues with a 
calculated Mt of 48 236 (Fig. 1). Sequence analysis of the 
other 14 positive clones established that they were shorter 
cDNA clones identical to portions of BIK. The nucleotide 
sequence of the coding region is 84% identical to the mouse 
Kir2.1 [30] with seven amino-acid differences. Sequence com-
parison of both the 5' and 3' non-coding regions of BIK to 
the corresponding regions in the mouse Kir2.1 [30] reveals 
overall low homology although stretches of high homology 
exist. Hydrophobicity analysis of the BIK amino-acid se-
quence shows the presence of two transmembrane segments 
(Ml and M2), and the pore-forming region H5 which is char-
acteristic of inwardly rectifying K+ channels [38,39]. The BIK 
sequence has putative phosphorylation sites for protein kinase 
C (residues 3, 6, 357 and 383), protein kinase A (residue 425), 
and tyrosine kinase (residues 242 and 366). 
3.2. Northern blot analysis of BIK mRNA in shear-stressed 
BAECs 
In order to determine if BIK mRNA is altered by shear 
stress, BAECs were subjected to flow prior to RNA isolation. 
Northern blot analysis was used to compare BIK mRNA 
from clonal BAECs exposed to shear stress to BIK mRNA 
from non-sheared control cells. BIK is expressed in BAECs as 
a single mRNA with estimated size of 5.5 kb (Fig. 2A). Fig. 
2B demonstrates that BIK mRNA is significantly reduced in 
BAECs exposed to 30 dyn/cm2 shear stress for 24 h as com-
pared with RNA from BAECs not exposed to shear stress. 
GAPDH served as the internal standard to normalize the BIK 
signal because the expression of GAPDH in BAECs is not 
affected by changes in shear stress [40]. The GAPDH signal 
indicates equal RNA was loaded in each lane. 
3.3. Electrophysiological properties of BIK 
The electrophysiological properties of BIK were examined 
using a Xenopus oocyte expression system. When expressed in 
oocytes, BIK produced a current (/BK) that was activated at 
hyperpolarized potentials (Fig. 3A). /BK was rapidly activating 
and showed slight inactivation over the time course of the 
voltage pulses (Fig. 3A). /BK increased in a nonlinear fashion 
as a function of external [K+] (Fig. 3A,B). No significant 
inward current was observed in uninjected or water-injected 
oocytes under similar conditions (data not shown). The volt-
age at which /BK rectified shifted to lower potentials at lower 
external [K+] (Fig. 3B). The BIK current in oocytes was 
highly potassium selective; the potential at which the current 
reverses changed 55.8 mV per decade change in external [K+] 
(Fig. 3C). 
External Ba2+ (Fig. 4A) and Cs+ (Fig. 4B) both exhibited a 
concentration- and voltage-dependent block of /BK which is 
typical for inward rectifier currents [41,42]. Both Ba2+ and 
Cs+ demonstrated a greater block of the steady-state current 
at more negative potentials (Fig. 4A,B). We examined the 
voltage dependence of the Cs+ and Ba2+ block by first deter-
mining the Ki (concentration producing 50% block) for each 
at a variety of voltages. This is done by plotting [steady-state 
current level without blocker]/[steady-state current level with 
blocker] versus the external blocker concentration. The K is 
the inverse slope of the linear fit of the data. Fig. 4C shows 
this graph for various [Cs+]. The K¡ for Ba2+ was similarly 
calculated to be 89 ± 7 μΜ at -120 mV (n = 5). The Woodhull 
model of ionic blockage of channels [43] was used to quantify 
the voltage dependence of the Cs+ block. The logarithms of 
the K\ values for Cs+ were plotted against the membrane 
potential (Fig. 4D). A 10-fold change in K corresponds to a 
change in membrane potential of 37 mV. This implies that the 
fractional distance of the Cs+ binding site in the membrane 
electric field is 1.6, which is similar to the Cs+ block observed 
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5 ' . . .GCGCCAGCAACAGGACCTGTTCTCTGGATGTCAGCTGAGTTACTAAGGTGACTCTGCATGTCAAGAGACAGACCTTGGTAGCCAGAACCTCAAGGCCCCTGGAGACCCCATCCC -120 
TCCTTCTTTTTTTGTGCGTGTGGGTCCTCACTGAACATTCAAACCTGTTTCTCCAAAGGGTTTTGCAAAAACTGAGACTGTTTCCCAAAGCAGAAGCGCTGGCGTCCACAGCAGAAGCG -1 
Φ Φ 
Met Gly Ser Val Arg Thr Asn Arg Tyr Ser lie Val Ser Ser Glu Glu Asp Gly Met Lys Leu Ala Thr Leu Ala Val Ala Asn Gly Phe 30 
ATG GGC AGC GTG CGC ACC AAC CGC TAC AGC ATC GTC TCT TCA GAG GAG GAC GGC ATG AAG CTG GCC ACC CTG GCG GTG GCC AAC GGA TTC 9 0 
Gly Asn Gly Lys Ser Lys Val His Thr Arg Gin Gin Cys Arg Ser Arg Phe Val Lys Lys Asp Gly His Cys Asn Val Gln Phe He Asn 60 
GGG AAT GGC AAG AGC AAA GTC CAC ACC CGC CAG CAG TGC AGG AGC CGC TTC GTG AAG AAG GAC GGA CAC TGC AAC GTG CAG TTC ATC AAC 180 
Val Gly Glu Lys Gly Gin Arg Tyr Leu Ala Asp He Phe Thr Thr Cys Val Asp He Arg Trp Arg Trp Met Leu Val H e Phe Cys Leu 90 
GTG GGC GAG AAG GGC CAG CGG TAC CTG GCG GAC ATC TTC ACC ACG TGC GTG GAC ATC CGC TGG CGG TGG ATG CTG GTC ATC TTC TGC CTG 270 
Ml 
Ala Phe Val Leu Ser Trp Leu Phe Phe Gly Cys Val Phe Trp Leu He Ala Leu 
GCT TTC GTG CTC TCC TGG CTC TTC TTC GGC TGT GTG TTT TGG TTG ATC GCG CTG 
Leu His Gly Asp Leu Asp Ala Ser Lys Glu Ser Lys 120 
CTC CAC GGG GAC CTG GAT GCG TCC AAG GAG AGC AAA 3 60 
H5 
Ala Cys Val Ser Glu Val Asn Ser Phe Thr Ala 
GCC TGC GTG TCC GAG GTC AAC AGC TTC ACG GCT 
Ala Phe Leu Phe Ser He Glu Thr Gln Thr Thr He Gly Tyr Gly Phe Arg Cys 
GCC TTC CTT TTC TCC ATC GAG ACG CAG ACC ACC ATC GGC TAC GGC TTC CGC TGC 
Val 150 
GTC 450 
M2 
Thr Asp Glu Cys Pro VallAla Val Phe Met Val Val Phe Gln Ser He Val Gly Cys He He Asp Ala Phe He He Gly AlalVal Met 180 
ACG GAC GAG TGC CCT GTG GCC GTC TTC ATG GTG GTC TTC CAG TCC ATC GTG GGC TGC ATC ATC GAC GCC TTC ATC ATC GGT GCG GTA ATG 54 0 
Ala Lys MET Ala Lys Pro Lys Lys Arg Asn Glu Thr Leu Val Phe Ser His Asn Ala Val He Ala Met Arg Asp Gly Lys Leu Cys Leu 210 
GCC AAG ATG GCC AAG CCC AAA AAG AGA AAC GAG ACG CTG GTC TTC AGC CAC AAC GCC GTG ATC GCC ATG AGG GAC GGC AAG CTC TGC CTC 630 
Met Trp Arg Val Gly Asn Leu Arg Lys Ser His Leu Val Glu Ala His Val Arg Ala Gln Leu Leu Lys Ser Arg H e Thr Ser Glu Gly 240 
ATG TGG CGG GTG GGC AAC CTC CGG AAG AGC CAC TTG GTG GAG GCG CAC GTG CGC GCG CAG CTC CTC AAG TCC AGA ATC ACC TCC GAG GGG 72 0 
Φ 
Glu Tyr He Pro Leu Asp Gln He Asp H e Asn Val Gly Phe Asp Ser Gly He Asp Arg He Phe Leu Val Ser Pro H e Thr He Val 270 
GAG TAC ATC CCC CTG GAT CAG ATA GAC ATC AAC GTG GGC TTC GAC AGC GGC ATC GAC CGC ATA TTT CTG GTG TCT CCC ATC ACC ATC GTC 810 
His Glu He Asp Glu Asp Ser Pro Leu Tyr Asp Leu Ser Lys Gln Asp H e Asp Asn Ala Asp Phe Glu H e Val Val H e Leu Glu Gly 300 
CAC GAG ATC GAT GAG GAC AGT CCT CTG TAC GAT CTG AGC AAG CAG GAC ATC GAC AAC GCA GAC TTT GAG ATC GTG GTC ATC CTC GAG GGT 9 00 
Met Val Glu Ala Thr Ala Met Thr Thr Gln Cys Arg Ser Ser Tyr Leu Ala Asn Glu He Leu Trp Gly His Arg Tyr Glu Pro Val Leu 330 
ATG GTG GAG GCC ACG GCC ATG ACC ACG CAG TGC CGG AGC TCG TAC CTG GCC AAC GAG ATC CTC TGG GGT CAC CGC TAC GAG CCG GTG CTC 990 
Φ 
Phe Glu Glu Lys His Tyr Tyr Lys Val Asp Tyr Ser Arg Phe His Lys Thr Tyr Glu Val Pro Asn Thr Pro Leu Cys Ser Ala Arg Asp 360 
TTC GAG GAG AAA CAC TAC TAC AAA GTA GAC TAC TCC AGG TTC CAC AAG ACG TAC GAA GTC CCC AAC ACG CCC CTG TGC AGC GCT AGG GAC 1080 
Φ Φ 
Leu Ala Glu Lys Lys Tyr H e Leu Ser Asn Ala Asn Ser Phe Cys Tyr Glu Asn Glu Val Ala Leu Thr Ser Lys Glu Glu Asp Asp Ser 390 
TTA GCG GAG AAG AAA TAC ATC CTG TCG AAC GCT AAC TCG TTT TGC TAC GAA AAT GAG GTC GCC CTC ACG AGC AAA GAG GAA GAC GAC AGT 1170 
Glu Asn Gly Val Pro Glu Ser Thr Ser Thr Asp Thr Pro Pro Asp He Asp Leu His Asn Gln Ala Ser Val Pro Leu Glu Pro Arg Pro 420 
GAG AAC GGG GTC CCC GAG AGC ACÁ AGC ACG GAC ACG CCC CCG GAC ATA GAC CTG CAC AAC CAG GCC AGT GTA CCT CTA GAG CCC AGG CCG 1260 
Leu Arg Arg Glu Ser Glu H e - 427 
TTA CGA CGG GAG TCG GAG ATA TGA CTGAGTCCTCCTGGGGAGTGCTTCCTGTGAAACACGGTCTGTTGGTCAAAGGCCCAAAACAGTTACGCACACGACGGTACCAGGGGC 1371 
CTGAGTCCTCCTGGGGAGTGCTTCCTCTGAAACACGGTCTGTTGGTCAAAGGCCCAAAACAGTTACGCACACGACGGTACCAGGGGCAGGTGGTTCGAGGCAAGTGACCACAAGGGACT 14 9 0 
GGGGCTAGCGCGGTGGTTTTAGAGAAAGACTGTAAGCGCGAAGACGA. . . 3 ' 
Fig. 1. Nucleotide and deduced amino acid sequences of BIK. Nucleotides numbered from the initiating ATG and amino acid residues num-
bered from the initiating MET. Boxed regions are the putative transmembrane regions (Ml and M2) and the pore forming region (H5). φ indi-
cates potential phosphorylation sites for protein kinase C (S3, T6, S357, T383), protein kinase A (S425) and tyrosine kinase (Y242, Y366). Res-
idues in bold (N172 and E224) are required for the strong rectification of the mouse Kir2.1 [54-56]. Only part of the 5' and 3' untranslated 
nucleotide sequences are shown. 
Fig. 2. Northern blot analysis of BIK mRNA. A: Expression of BIK mRNA (~5.5 kb) in clonal bovine aortic endothehal cells. B: Compari-
son of BIK mRNA expression in sheared versus static controls in BAECs. GAPDH mRNA ( ~ 1.4 kb) expression also shown. RNA size 
markers (BRL) are shown on the left of (A). 
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Fig. 3. Inwardly rectifying currents from BIK expressed in Xenopus oocytes. A: Currents were recorded from an BIK cRNA injected oocyte 
that was clamped at —40 mV and subjected to 260 ms test potentials ranging from —110 mV to +20 mV in 10 mV increments. B: Current-
voltage relationships obtained from same oocyte as (A). Current amplitudes at 100 ms after initiation of pulses are plotted against the mem-
brane potential. Concentration of external K+: ■. 90 mM; · , 60 mM, ▲, 30 mM; ♦, 2 mM. C: Semilogarithmic plot of extracellular K+ 
concentration versus reversal potential. Data shows mean ± SE for three oocytes. The straight line is a best fit of the data. 
in the Kir2.1 channel cloned from mouse [30]. This result is 
indicative of a multi-ion block of permeant (K+) and blocking 
(Cs+) ions in a multi-ion pore [44]. TEA was a much less 
potent blocker of IBK then either Ba2+ or Cs+ with a K¡ of 
39±3 mM at -110 mV (n = 5). 
The sensitivity of IBK to four antiarrhythmic agents was 
examined by application of the drugs to oocytes previously 
injected with BIK specific cRNA. Quinidine and compound II 
were the most potent inhibitors of the BIK mediated currents 
(Fig. 5A,D). The X¡ values for quinidine and compound II 
were determined to be 110 ±30 μΜ and 39 ± 14 μΜ at -130 
mV respectively (n - 3-5). These K¡ values did not demon-
strate any voltage dependence. Disopyramide and sotalol 
both showed only small effects on IBK (Fig. 5B,C). 
4. Discussion 
In this report we describe the cDNA cloning and functional 
expression of a bovine aortic endothelial cell K+ inward rec-
tifier channel, BIK. We present the entire primary structure 
and characterize the electrophysiological properties of the 
clone. Inhibition of the BIK current by a variety of cations 
and pharmacological agents are reported. Finally, we demon-
strate that the expression of BIK messenger RNA in BAECs 
is significantly reduced in response to fluid flow. 
The BIK induced current (IBK) shares electrophysiological 
properties with the endothelial cell current (/κι)· IBK and Τκι 
have similar strongly inwardly rectifying whole cell current-
voltage relationships, they both show rapid activation ki-
netics, and they are both blocked by extracellular Ba2+ and 
Cs+ at similar concentrations [8,11,12,18]. Both currents re-
spond to increases in extracellular potassium with an increase 
in their respective current reversal potentials and an increase 
in their slope conductances [12]. Because of these similarities 
we propose that BIK is the predominant inward rectifier de-
scribed in endothelial cells. 
Regulation of a K+ current in BAECs could have signifi-
cant impact on a variety of cell signal transduction systems. 
BIK mRNA was found to be greatly decreased in BAECs 
exposed to 30 dyn/cm2 shear stress for 24 h. Therefore the 
cells regulate ion channel mRNA as a response to the shear-
stress environment. This result is significant because it is the 
first report of the shear-stress regulation of a primary signal-
ing molecule in endothelial cells. The regulation of several 
genes in BAECs has been shown to be sensitive to the level 
of shear stress induced by blood flow. These include genes 
encoding basic fibroblast growth factor [45], nitric oxide syn-
thase [46,47], transforming growth factor ßl [48] and endo-
thelin I [49]. The regulation of BIK may have affects on a 
wide range of other shear-related events including the regula-
tion of the genes mentioned above. 
Antiarrhythmic agents are in widespread clinical use for the 
management of cardiac arrhythmias [50]. These drugs inhibit 
cardiac ion channels. BIK has structural and functional sim-
ilarity to cardiac ion channels. Two different drugs, quinidine, 
a class la agent, and compound II, a class III agent, were each 
found to significantly inhibit IBK at physiologically relevant 
concentrations [34,37]. Interestingly, sotalol, a close analog of 
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Fig. 4. Analysis of /BK block by Ba2+ and Cs+. A: Current-voltage relationships for representative oocyte in various concentrations of Ba2+: 
· , 30 μΜ; ▲, 100 μΜ; ♦ , 300 μΜ; Τ , 1 mM. B: Current-voltage relationships for representative oocyte in various concentrations of Cs+ : 
· , 100 μΜ; ▲, 300 μΜ; ♦ , 1 mM; T , 3 mM. In both (A) and (B) the ■ symbol represents no drug. Cell subjected to 260 ms voltage steps 
in 10 mV increments between —150 mV and +20 mV from a holding potential of —40 mV in ND96. Current amplitudes measured 100 ms 
after initiation of test pulses. C: Plot of the ratios of steady-state current levels in the absence and presence of Cs+ as a function of [Cs+]0 at 
the indicated membrane potentials: ■. —140 mV; · , —130 mV; A, —120 mV; ♦ , —110 mV. Least squares fit derived from /o//cs+ = l+[Cs+]/ 
(1+Äi) [57]. D: Logarithms of A¡ values for Cs+ block plotted as a function of voltage. Data in (C) and (D) shows the mean±SE for five 
oocytes. 
Fig. 5. Analysis of /BK inhibition by four antiarrhythmic agents. I/V plots obtained from representative oocytes as in Fig. 4. The ■ symbol rep-
resents the control (no agent) in each plot. Drugs and concentrations: (A) quinidine: · , 10 μΜ; A, 100 μΜ; (Β) disopyramide: · , 180 μΜ; 
A, 720 μΜ; (C) sotalol: · , 250 μΜ; A, 1 mM; (D) compound II · , 10 μΜ; A, 50 μΜ. 
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compound II [51], displayed very little inhibition of TBK- This 
is the first report of the inhibition of an endothelial cell ion 
channel with these agents. These results indicate that both 
quinidine and compound II may have significant effects on 
vascular endothelial cells. 
The BIK current may be the primary determinant of resting 
potential in endothelial cells. Modulat ion of BIK current by 
shear stress or other factors would have a direct effect on the 
membrane potential. Since the influx of extracellular calcium 
is dependent on Vm, an understanding of resting potential 
maintenance is crucial to understanding calcium homeostasis 
within endothelial cells. Moreover, it has been postulated that 
endothelial cells are electrically coupled not only to each other 
but also to vascular smooth muscle cells [52,53]. Thus the 
maintenance of a hyperpolarized membrane potential may 
be of importance to both endothelial cell function and vascu-
lar smooth muscle cell relaxation. 
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